Hayden Panettiere’s Death Sparks Renewed Backlash Against Neutrogena
Following the death of actress Hayden Panettiere at age 36 on August 16, a wave of digital backlash has targeted cosmetics giant Neutrogena. Fans and social media users have resurfaced revelations from the actress’s final months, including allegations that the Kenvue-owned brand attempted to cut ties with her in 2015 after she spoke openly on television about experiencing postpartum depression.
Memoir Revelations and the 2015 Television Broadcast
The renewed scrutiny stems from details Panettiere shared in her 2026 memoir, “This Is Me: A Reckoning,” and subsequent promotional interviews conducted in May. During a September 2015 appearance on “Live with Kelly and Michael,” the “Heroes” star discussed her personal experience with postpartum depression following the birth of her daughter, Kaya, noting that the condition is uncontrollable, painful, and widely misunderstood.
According to Panettiere’s accounts on Jay Shetty’s “On Purpose” podcast and in cover stories published in May, that television appearance abruptly derailed her decade-long endorsement deal with Neutrogena. She stated that corporate representatives informed her representative that discussing the mood disorder violated the brand’s morals clause, leading to an ultimatum that she be dropped from future campaigns.
Public Backlash and Social Media Boycotts
As news of Panettiere’s passing spread on August 16, internet users redirected their grief into digital activism against the skincare brand. Platforms including Reddit saw a surge of negative sentiment, with one Reddit thread garnering over 2,500 upvotes calling for an organized consumer boycott. Comment sections across Neutrogena’s official social media accounts filled with tens of thousands of likes condemning the brand’s historic handling of the talent.
Industry Repercussions and Legal Boundaries
During her May promotional tour, Panettiere recounted to The Hollywood Reporter that her legal representation at the time informed her that attempting to terminate a contract over a medical disclosure like postpartum depression crossed legal lines. Despite intervention that preserved her standing for the immediate term, she noted she was quietly phased out afterward, receiving no farewell acknowledgment after ten years of partnership.
USA TODAY reached out to Neutrogena for comment regarding the renewed backlash, though the brand did not respond to multiple outlet inquiries when the allegations initially surfaced in May.
*Disclaimer: The views and cultural analyses presented in this article are for informational and entertainment purposes only. Information regarding legal disputes or financial data is based on available public records.*